Zura Bio Company Insiders
ZURA Stock | 1.39 0.01 0.71% |
Zura Bio employs about 14 people. The company is managed by 10 executives with a total tenure of roughly 33 years, averaging almost 3.0 years of service per executive, having 1.4 employees per reported executive. Analysis of Zura Bio's management performance can provide insight into the company performance.
Insider Sentiment 50
Impartial
Selling | Buying |
Latest Trades
2024-11-25 | Parvinder Thiara | Disposed 1001633 @ 2.73 | View | ||
2024-09-04 | Someit Sidhu | Disposed 51728 @ 3.87 | View | ||
2024-05-17 | Van Amstel Arnout Ploos | Acquired 80000 @ 6.2 | View | ||
2024-04-22 | Michael Howell | Acquired 7987 @ 3.13 | View |
Monitoring Zura Bio's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Zura |
Zura Bio Management Team Effectiveness
The company has return on total asset (ROA) of (0.214) % which means that it has lost $0.214 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3685) %, meaning that it created substantial loss on money invested by shareholders. Zura Bio's management efficiency ratios could be used to measure how well Zura Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.65. The current year's Return On Capital Employed is expected to grow to -0.85. At present, Zura Bio's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 121.8 M, whereas Total Assets are forecasted to decline to about 90.6 M.As of March 21, 2025, Common Stock Shares Outstanding is expected to decline to about 24.8 M. In addition to that, Net Loss is expected to decline to about (42.7 M)
Zura Bio Workforce Comparison
Zura Bio Limited is rated first in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 104,852. Zura Bio adds roughly 14.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Zura Bio Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zura Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zura Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zura Bio insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zura Bio Notable Stakeholders
A Zura Bio stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zura Bio often face trade-offs trying to please all of them. Zura Bio's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zura Bio's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert Lisicki | President COO | Profile | |
Kimberly JD | COO Officer | Profile | |
Someit MD | Founder Director | Profile | |
Gary Whale | Chief Officer | Profile | |
David Brady | Head Development | Profile | |
Kiran MBBS | Chief Development | Profile | |
Kimberly Davis | Chief Secretary | Profile | |
Theresa Lowry | Chief Officer | Profile | |
Verender Badial | Chief Officer | Profile | |
Michael Howell | Chief Medicine | Profile |
About Zura Bio Management Performance
The success or failure of an entity such as Zura Bio Limited often depends on how effective the management is. Zura Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zura management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zura management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.69) | (0.65) | |
Return On Capital Employed | (0.89) | (0.85) | |
Return On Assets | (0.69) | (0.65) | |
Return On Equity | (1.17) | (1.11) |
Please note, the presentation of Zura Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zura Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Zura Bio's management manipulating its earnings.
Zura Bio Workforce Analysis
Traditionally, organizations such as Zura Bio use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zura Bio within its industry.Zura Bio Manpower Efficiency
Return on Zura Bio Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 4.3M | |
Net Loss Per Executive | 6.1M | |
Working Capital Per Employee | 5.8M | |
Working Capital Per Executive | 8.1M |
Complementary Tools for Zura Stock analysis
When running Zura Bio's price analysis, check to measure Zura Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zura Bio is operating at the current time. Most of Zura Bio's value examination focuses on studying past and present price action to predict the probability of Zura Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zura Bio's price. Additionally, you may evaluate how the addition of Zura Bio to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |